Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma

Capecchi, Pier Leopoldo ; Lazzerini, Pietro Enea

Annals of the rheumatic diseases, 2022-11, Vol.81 (11), p.e214-e214 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível